HKSE - Delayed Quote HKD

OCUMENSION-B (1477.HK)

5.290
+0.070
+(1.34%)
At close: 4:08:05 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
417,307
417,307
246,367
158,957
56,146
Cost of Revenue
192,242
192,242
102,002
56,041
19,211
Gross Profit
225,065
225,065
144,365
102,916
36,935
Operating Expense
529,142
529,142
545,705
551,141
422,479
Operating Income
-304,077
-304,077
-401,340
-448,225
-385,544
Net Non Operating Interest Income Expense
20,056
20,056
20,595
26,428
26,318
Pretax Income
-267,257
-267,257
-379,480
-402,229
-259,992
Tax Provision
1,017
1,017
307
414
0
Net Income Common Stockholders
-268,274
-268,274
-379,787
-402,643
-259,992
Diluted NI Available to Com Stockholders
-268,274
-268,274
-379,787
-402,643
-259,992
Basic EPS
-0.50
-0.39
-0.59
-0.64
-0.43
Diluted EPS
-0.50
-0.39
-0.59
-0.64
-0.43
Basic Average Shares
655,651.318
687,882.051
643,706.780
632,531.914
607,143.512
Diluted Average Shares
655,651.318
687,882.051
643,706.780
632,531.914
607,143.512
Total Expenses
721,384
721,384
647,707
607,182
441,690
Net Income from Continuing & Discontinued Operation
-268,274
-268,274
-379,787
-402,643
-259,992
Normalized Income
-267,544.250
-267,544.250
-382,775.750
-400,238.500
-385,769
Interest Income
22,219
22,219
21,920
28,221
26,885
Interest Expense
2,163
2,163
1,325
1,793
567
Net Interest Income
20,056
20,056
20,595
26,428
26,318
EBIT
-265,094
-265,094
-378,155
-400,436
-259,425
EBITDA
-176,480
-176,480
-320,619
-359,978
-245,527
Reconciled Cost of Revenue
192,242
192,242
102,002
56,041
19,211
Reconciled Depreciation
88,614
88,614
57,536
40,458
13,898
Net Income from Continuing Operation Net Minority Interest
-268,274
-268,274
-379,787
-402,643
-259,992
Total Unusual Items Excluding Goodwill
-973
-973
3,985
-3,206
125,777
Total Unusual Items
-973
-973
3,985
-3,206
125,777
Normalized EBITDA
-175,507
-175,507
-324,604
-356,772
-371,304
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-243.250
-243.250
996.250
-801.500
0
12/31/2021 - 7/10/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2256.HK Abbisko Cayman Limited
7.830
+1.69%
 
2105.HK Laekna, Inc.
14.900
+4.20%
 
2410.HK TYK Medicines, Inc
30.950
+1.98%
 
3759.HK Pharmaron Beijing Co., Ltd.
13.620
-1.30%
 
2696.HK Shanghai Henlius Biotech, Inc.
35.250
-0.70%
 
1548.HK GENSCRIPT BIO
10.920
-1.80%
 
9995.HK RemeGen Co., Ltd.
37.450
-3.48%
 
6160.HK BeiGene, Ltd.
140.400
-0.21%
 
9939.HK Kintor Pharmaceutical Limited
1.260
+0.80%
 
1530.HK 3SBIO
12.080
+4.50%